Table of Contents Author Guidelines Submit a Manuscript
Obstetrics and Gynecology International
Volume 2015, Article ID 817849, 13 pages
http://dx.doi.org/10.1155/2015/817849
Review Article

N-Acetylcysteine for Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials

1Department of Pharmacology, SAL Institute of Pharmacy, Ahmadabad, Gujarat 380060, India
2Department of Pharmaceutical Systems and Policy, School of Pharmacy, West Virginia University, Morgantown, WV 26506, USA
3Department of Biopharmaceutical Sciences, Bernard J. Dunn School of Pharmacy, Shenandoah University, Winchester, VA 22601, USA
4Department of Endocrinology, Post-Graduate Medical Education and Research Institute (PGIMER), Chandigarh 160012, India

Received 13 May 2014; Accepted 31 August 2014

Academic Editor: Curt W. Burger

Copyright © 2015 Divyesh Thakker et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Shannon and Y. Wang, “Polycystic ovary syndrome: a common but often unrecognized condition,” Journal of Midwifery & Women's Health, vol. 57, no. 3, pp. 221–230, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. B. O. Yildiz, G. Bozdag, Z. Yapici, I. Esinler, and H. Yarali, “Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria,” Human Reproduction, vol. 27, no. 10, pp. 3067–3073, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Christakou and E. Diamanti-Kandarakis, “Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome,” Women's Health, vol. 4, no. 6, pp. 583–594, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Huang, K. Brennan, and R. Azziz, “Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria,” Fertility and Sterility, vol. 93, no. 6, pp. 1938–1941, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. American Association of Clinical Endocrinologists Polycystic Ovary Syndrome Writing Committee, “American association of clinical endocrinologists position statement on metabolic and cardiovascular consequences of polycystic ovary syndrome,” Endocrine Practice, vol. 11, no. 2, pp. 126–134, 2005. View at Google Scholar
  6. B. Pangaribuan, I. Yusuf, M. Mansyur, and A. Wijaya, “Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome,” Therapeutic Advances in Endocrinology and Metabolism, vol. 2, no. 6, pp. 235–245, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Brown, C. Farquhar, J. Beck, C. Boothroyd, and E. Hughes, “Clomiphene and anti-oestrogens for ovulation induction in PCOS,” The Cochrane Database of Systematic Reviews, no. 4, Article ID CD002249, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. C. M. Farquhar, Y. A. Wang, and E. A. Sullivan, “A comparative analysis of assisted reproductive technology cycles in Australia and New Zealand 2004–2007,” Human Reproduction, vol. 25, no. 9, pp. 2281–2289, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Farquhar, J. Brown, and J. Marjoribanks, “Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome,” Cochrane Database of Systematic Reviews, vol. 6, Article ID CD001122, 2012. View at Publisher · View at Google Scholar
  10. K. A. Awartani and A. P. Cheung, “Metformin and polycystic ovary syndrome: a literature review,” Journal of Obstetrics and Gynaecology Canada, vol. 24, no. 5, pp. 393–401, 2002. View at Google Scholar · View at Scopus
  11. T. Tang, J. M. Lord, R. J. Norman, E. Yasmin, and A. H. Balen, “Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility,” Cochrane Database of Systematic Reviews, no. 5, Article ID CD003053, 2012. View at Publisher · View at Google Scholar
  12. D. Moher, A. Liberati, J. Tetzlaff, D. G. Altman, and The PRISMA Group, “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement,” PLoS Medicine, vol. 6, no. 6, Article ID e1000097, 2009. View at Publisher · View at Google Scholar
  13. A. M. Fulghesu, M. Ciampelli, G. Muzj et al., “N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome,” Fertility and Sterility, vol. 77, no. 6, pp. 1128–1135, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Elnashar, M. Fahmy, A. Mansour, and K. Ibrahim, “N-acetyl cysteine vs. metformin in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective randomized controlled study,” Fertility and Sterility, vol. 88, no. 2, pp. 406–409, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, “Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome,” Fertility and Sterility, vol. 81, no. 1, pp. 19–25, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Zawadzki and A. Dunaif, “A. diagnostic criteria for polycystic ovary syndrome: towards a rational approach,” in Polycystic Ovarian Syndrome, A. Dunaif, J. Givens, F. Haseltine, and G. Merriam, Eds., pp. 377–84, Blackwell Scientific, Boston, Mass, USA, 1992. View at Google Scholar
  17. S. Salehpour, M. Tohidi, M. R. Akhound, and N. Amirzargar, “N acetyl cysteine, a novel remedy for poly cystic ovarian syndrome,” International Journal of Fertility and Sterility, vol. 3, no. 2, pp. 66–73, 2009. View at Google Scholar · View at Scopus
  18. G. Oner and I. I. Muderris, “Clinical, endocrine and metabolic effects of metformin vs N-acetyl-cysteine in women with polycystic ovary syndrome,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 159, no. 1, pp. 127–131, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Salehpour, A. A. Sene, N. Saharkhiz, M. R. Sohrabi, and F. Moghimian, “N-acetylcysteine as an adjuvant to clomiphene citrate for successful induction of ovulation in infertile patients with polycystic ovary syndrome,” Journal of Obstetrics and Gynaecology Research, vol. 38, no. 9, pp. 1182–1186, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Y. Rizk, M. A. Bedaiwy, and H. G. Al-Inany, “N-acetyl-cysteine is a novel adjuvant to clomiphene citrate in clomiphene citrate-resistant patients with polycystic ovary syndrome,” Fertility and Sterility, vol. 83, no. 2, pp. 367–370, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. H. A. Hashim, K. Anwar, and R. A. El-Fatah, “N-acetyl cysteine plus clomiphene citrate versus metformin and clomiphene citrate in treatment of clomiphene-resistant polycystic ovary syndrome: a randomized controlled trial,” Journal of Women's Health, vol. 19, no. 11, pp. 2043–2048, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Nasr, “Effect of N-acetyl-cysteine after ovarian drilling in clomiphene citrate-resistant PCOS women: a pilot study,” Reproductive BioMedicine Online, vol. 20, no. 3, pp. 403–409, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Liberati, D. G. Altman, J. Tetzlaff et al., “The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration,” PLoS Medicine, vol. 6, no. 7, Article ID e1000100, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. J. P. T. Higgins and S. Green, Eds., Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0, The Cochrane Collaboration, 2011, http://handbook.cochrane.org.
  25. J. P. T. Higgins, S. G. Thompson, J. J. Deeks, and D. G. Altman, “Measuring inconsistency in meta-analyses,” British Medical Journal, vol. 327, no. 7414, pp. 557–560, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. R. D. Riley, J. P. Higgins, and J. J. Deeks, “Interpretation of random effects meta-analyses,” British Medical Journal, vol. 342, article d549, 2011. View at Publisher · View at Google Scholar
  27. T. Kilic-Okman and M. Kucuk, “N-acetyl-cysteine treatment for polycystic ovary syndrome,” International Journal of Gynecology & Obstetrics, vol. 85, no. 3, pp. 296–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Gayatri, J. S. Kumar, and B. B. Kumar, “Metformin and N-acetyl cysteine in polycystic ovarian syndrome—a comparative study,” Indian Journal of Clinical Medicine, vol. 1, no. 1, pp. 7–13, 2010. View at Google Scholar